Maria Pia Giannoccaro,Lucrezia Serra,Ana Gabriela Grondona et al.
Maria Pia Giannoccaro et al.
Background and objectives: Antibody testing has a pivotal role in the diagnosis of myasthenia gravis (MG). However, there are limited data on the accuracy of the different methods available for acetylcholine receptor (ACh...
Multicenter Study
Neurology. 2026 Sep 8;107(5):e218301. DOI:10.1212/WNL.0000000000218301 2026
Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment [0.03%]
与标准磁共振成像评估相比，大脑年龄在主观性以及轻度认知障碍中的痴呆风险分层作用分析
Stefan De Vries,Katalin Farkas,Hanneke F M Rhodius-Meester et al.
Stefan De Vries et al.
Background and objectives: Early dementia risk-stratification is crucial for timely intervention. Brain-predicted age difference (brain-PAD) derived from structural MRI reflects the gap between computer-estimated age and ...
Comparative Study
Neurology. 2026 Sep 8;107(5):e218418. DOI:10.1212/WNL.0000000000218418 2026
Clinical Reasoning: A 79-Year-Old Man With Subacute Onset Involuntary Facial Movements and Discoordination [0.03%]
临床思维：一名79岁男性患者，亚急性发作性面部不自主运动和共济失调病例的思考
Amara Plaza-Jennings,Prashanth Rajarajan,Meabh O&#x;Hare et al.
Amara Plaza-Jennings et al.
A 79-year-old man with metastatic Merkel cell carcinoma undergoing cancer-directed treatment was admitted to the hospital with 1 week of bilateral upper and lower extremity tremor and nearly continuous involuntary facial movements. These ab...
Case Reports
Neurology. 2026 Sep 8;107(5):e218383. DOI:10.1212/WNL.0000000000218383 2026
Qiang Fang,Xiuhe Zhao,Jingzhen He
Qiang Fang
Machine Learning Characterization of Readmissions After Chronic Subdural Hematoma Hospitalizations [0.03%]
基于机器学习的慢性硬膜下血肿住院后再入院的风险预测模型
Huanwen Chen,Marco Colasurdo,Matthew K McIntyre et al.
Huanwen Chen et al.
Background and objectives: Readmission after chronic or subacute subdural hematoma (cSDH/sSDH) hospitalization is common, yet clinical attention and trial design have focused primarily on surgical recurrence. The full spe...
Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease [0.03%]
儿童少突胶质细胞髓鞘糖蛋白抗体相关疾病的急性发作治疗升级与随后的复发风险关系研究
Silvia Bartolomeo,Riccardo Nistri,Nee Na Kim et al.
Silvia Bartolomeo et al.
Objectives: Acute treatment for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) includes high-dose IV methylprednisolone (IVMP), with escalation to IV immunoglobulin (IVIG) and/or plasma exchange (...
Pearls & Oy-sters: Bilateral Neuropathic Facial Pain With Autonomic Features and Neurovascular Contact [0.03%]
珠丝暗涌：具有自主神经症状和颅神经血管接触的双侧痛性 cranial neuralgia
Vivian Ni,Kara-Marie Nedd
Vivian Ni
Trigeminal neuralgia (TN) is an uncommon disorder, with an annual prevalence of 0.03%-0.3% in North America. It is typically unilateral, most commonly involving the V2 and V3 distributions and may be accompanied by mild autonomic features. ...
Case Reports
Neurology. 2026 Sep 8;107(5):e218446. DOI:10.1212/WNL.0000000000218446 2026
Teaching Video NeuroImage: Treatment-Responsive Dystonia in THAP1-Associated Dystonia [0.03%]
教学视频神经影像：THAP1相关性肌张力障碍的治疗反应型 dystonia（多发性肌张力障碍）
Pradeep Kumar Gunasekaran,Arushi Gahlot Saini,Shagun Singh et al.
Pradeep Kumar Gunasekaran et al.
Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes [0.03%]
基于定量肌肉MRI和临床结果的Charcot-Marie-Tooth病I型疾病进展量化研究
Louise Iterbeke,Lotte Huysmans,Kobe Bamps et al.
Louise Iterbeke et al.
Background and objectives: Charcot-Marie-Tooth neuropathy type 1A (CMT1A) is a slowly progressive demyelinating neuropathy with distal muscle weakness and atrophy. Sensitive, objective outcome measures are needed for futu...
Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study [0.03%]
大脑损伤后意识障碍中的葡萄糖和蛋氨酸代谢：一项探索性的纵向PET研究
Tomohiro Yamaki,Nobuo Oka,Yoshinori Higuchi et al.
Tomohiro Yamaki et al.
Background and objectives: Brain glucose metabolism measured by [18F]fluorodeoxyglucose (FDG) PET is a marker of residual activity in disorders of consciousness (DoC). Brain amino acid metabolism remains poorly characteri...
Observational Study
Neurology. 2026 Sep 8;107(5):e218419. DOI:10.1212/WNL.0000000000218419 2026